(0.12%) 5 024.61 points
(0.20%) 37 979 points
(0.30%) 15 652 points
(-0.06%) $78.95
(3.42%) $1.998
(-0.37%) $2 302.50
(-0.11%) $26.72
(0.14%) $956.25
(0.38%) $0.937
(0.52%) $11.09
(0.39%) $0.802
(-1.20%) $92.14
Live Chart Being Loaded With Signals
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas...
Stats | |
---|---|
Šios dienos apimtis | 36 000.00 |
Vidutinė apimtis | 69 762.00 |
Rinkos kapitalizacija | 19.47B |
EPS | ¥0 ( 2024-04-12 ) |
Kita pelno data | ( ¥0 ) 2024-07-10 |
Last Dividend | ¥9.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 11.99 |
ATR14 | ¥0.519 (0.11%) |
Tūris Koreliacija
Astena Holdings Co., Ltd. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Astena Holdings Co., Ltd. Koreliacija - Valiuta/Žaliavos
Astena Holdings Co., Ltd. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | ¥51.98B |
Bruto pelnas: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2023 |
Pajamos: | ¥51.98B |
Bruto pelnas: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2022 |
Pajamos: | ¥49.64B |
Bruto pelnas: | ¥15.44B (31.11 %) |
EPS: | ¥14.56 |
FY | 2021 |
Pajamos: | ¥72.32B |
Bruto pelnas: | ¥16.60B (22.96 %) |
EPS: | ¥46.86 |
Financial Reports:
No articles found.
Astena Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.75 | 2001-05-28 |
Last Dividend | ¥9.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 38 | -- |
Total Paid Out | ¥149.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.32 | -- |
Div. Sustainability Score | 9.60 | |
Div.Growth Potential Score | 3.35 | |
Div. Directional Score | 6.47 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8345.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7730.T | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
6904.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6266.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
4977.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4189.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3392.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
2471.T | Ex Dividend Knight | 2023-11-29 | Annually | 0 | 0.00% | |
9409.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8074.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0306 | 1.500 | 9.39 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0245 | 1.200 | 9.18 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0583 | 1.500 | -0.463 | -0.695 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.262 | 0.800 | 8.69 | 6.95 | [1 - 3] |
quickRatioTTM | 0.843 | 0.800 | 9.75 | 7.80 | [0.8 - 2.5] |
cashRatioTTM | 0.162 | 1.500 | -0.210 | -0.315 | [0.2 - 2] |
debtRatioTTM | 0.236 | -1.500 | 6.06 | -9.09 | [0 - 0.6] |
interestCoverageTTM | 22.43 | 1.000 | 2.81 | 2.81 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.546 | -1.500 | 7.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.323 | 1.000 | 7.95 | 7.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0318 | 1.000 | -1.364 | -1.364 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.226 | 1.000 | 9.86 | 9.86 | [0.2 - 2] |
assetTurnoverTTM | 0.798 | 0.800 | 8.01 | 6.41 | [0.5 - 2] |
Total Score | 9.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.05 | 1.000 | 8.88 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0583 | 2.50 | -0.298 | -0.695 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.66 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.118 | 1.500 | -2.55 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0669 | 1.000 | -0.826 | 0 | [0.1 - 0.5] |
Total Score | 3.35 |
Astena Holdings Co., Ltd.
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division is involved in the biotechnology related business, such as the provision of drug development support services; and sale of medical equipment. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co.,Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.